Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 350, pseudogene (RN7SL350P)
- Target
- RN7SL350P
- Molecular classification
- Pseudogene, Non-coding RNA, Processed pseudogene
01
Overview
RNA, 7SL, cytoplasmic 350, pseudogene (RN7SL350P) is a processed pseudogene derived from the RNA, 7SL (cytoplasmic 1) gene, which encodes the 7SL RNA core component of the signal recognition particle (SRP), a ribonucleoprotein complex essential for targeting secretory and membrane proteins to the endoplasmic reticulum in eukaryotic cells. RN7SL350P itself does not produce a functional RNA or protein, and is not known to be involved in established biological pathways, nor is it regarded as a therapeutic target. Pseudogenes such as RN7SL350P are typically non-functional remnants of evolution, though rare pseudogenes can serve regulatory roles (e.g., as competitive endogenous RNAs, ceRNAs, or miRNA sponges), but there is currently no evidence for such a function for RN7SL350P specifically. It is not associated with known drug targeting, disease processes, or biomarker status.
- Other names
- RN7SL350P7SL RNA pseudogeneRNA, 7SL, cytoplasmic 350, pseudogene
02
Biological functions
None (pseudogenes generally do not have standard biological functions, but may act as regulatory non-coding RNAs in rare cases)
03
Disease associations
Other (no direct evidence links RN7SL350P to specific diseases; some processed pseudogenes can participate in disease via ceRNA/miRNA sponge effects, but no evidence for this specific pseudogene)
Beyond the preview
Go deeper on RNA, 7SL, cytoplasmic 350, pseudogene (RN7SL350P).
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow the clinical studies evaluating therapies directed at this target.
- Trial design
- Status
- Readouts
Competitive landscape
Full profile accessCompare approaches across drug candidates, modalities, and indications.
- Programs
- Modalities
- Indications
Literature & evidence
Full profile accessInvestigate the research and source evidence behind target biology and development.
- Publications
- Sources
- Analysis
Patents
Full profile accessExplore patent activity around therapies and technologies addressing this target.
- Patents
- Assignees
- Technologies
Research & analysis
Full profile accessConnect target biology, drug development, and emerging evidence in your research.
- Biology
- Development news
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 350, pseudogene (RN7SL350P).